A multiplex platform for the identification of ovarian cancer biomarkers

被引：0
|
作者：
Kristin L. M. Boylan
Kate Geschwind
Joseph S. Koopmeiners
Melissa A. Geller
Timothy K. Starr
Amy P. N. Skubitz
机构：
[1] University of Minnesota,Department of Laboratory Medicine and Pathology, School of Medicine
[2] University of Minnesota,Ovarian Cancer Early Detection Program
[3] University of Minnesota,Division of Biostatistics, School of Public Health
[4] University of Minnesota,Department of Obstetrics, Gynecology, and Women’s Health
[5] University of Minnesota,Masonic Cancer Center
[6] University of Minnesota,Department of Genetics, Cell Biology and Genetics
来源：
Clinical Proteomics | 2017年 / 14卷
关键词：
Ovarian cancer; Biomarkers; Multiplex; CA125; HE4; Proseek; Proximity extension assay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] A multiplex platform for the identification of ovarian cancer biomarkers
    Boylan, Kristin L. M.
    Geschwind, Kate
    Koopmeiners, Joseph S.
    Geller, Melissa A.
    Starr, Timothy K.
    Skubitz, Amy P. N.
    CLINICAL PROTEOMICS, 2017, 14
  • [2] Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform
    Fan, Lijun
    Zhang, Wang
    Yin, Mingzhu
    Zhang, Tao
    Wu, Xiaoyan
    Zhang, Haiyu
    Sun, Meng
    Li, Zhenzi
    Hou, Yan
    Zhou, Xiaohua
    Lou, Ge
    Li, Kang
    ACTA ONCOLOGICA, 2012, 51 (04) : 473 - 479
  • [3] Identification of novel ovarian cancer biomarkers.
    Lanner, C
    Liu, J
    Dai, H
    Hickey, RJ
    Malkas, LH
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6125S - 6125S
  • [4] Identification and Analysis of Gene Biomarkers for Ovarian Cancer
    Wang, Xiaodan
    Xie, Chengmao
    Lu, Chang
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2024, 28 (02) : 70 - 81
  • [5] Identification of Circulating Autoantibodies as Novel Ovarian Cancer Biomarkers
    Murphy, M. A.
    O'Connell, D. J.
    O'Brien, J. K.
    O'Toole, S.
    O'Kane, S. L.
    Martin, C.
    Sheils, O.
    O'Leary, J. J.
    Cahill, D. J.
    LABORATORY INVESTIGATION, 2012, 92 : 455A - 455A
  • [6] Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer
    Li, Chia-Jung
    Lin, Li-Te
    Chu, Pei-Yi
    Chiang, An-Jen
    Tsai, Hsiao-Wen
    Chiu, Yi-Han
    Huang, Mei-Shu
    Wen, Zhi-Hong
    Tsui, Kuan-Hao
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (04):
  • [7] Identification of novel biomarkers for early detection of ovarian cancer
    Szabo, Linda A.
    Khatri, Purvesh
    Liu, Xiaodan
    Hu, Zhongkai
    Ling, Bruce
    Butte, Atul J.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [8] Identification of candidate epigenetic biomarkers for ovarian cancer detection
    Huang, Yi-Wen
    Jansen, Rachel A.
    Fabbri, Enrica
    Potter, Dustin
    Liyanarachchi, Sandya
    Chan, Michael W. Y.
    Liu, Joseph C.
    Crijns, Anne P. G.
    Brown, Robert
    Nephew, Kenneth P.
    Van Der Zee, Ate G. J.
    Cohn, David E.
    Yan, Pearlly S.
    Huang, Tim H. -M.
    Lin, Huey-Jen L.
    ONCOLOGY REPORTS, 2009, 22 (04) : 853 - 861
  • [9] Identification of Circulating Autoantibodies as Novel Ovarian Cancer Biomarkers
    Murphy, M. A.
    O'Connell, D. J.
    O'Brien, J. K.
    O'Toole, S.
    O'Kane, S. L.
    Martin, C.
    Sheils, O.
    O'Leary, J. J.
    Cahill, D. J.
    MODERN PATHOLOGY, 2012, 25 : 455A - 455A
  • [10] Proteomic Based Identification of Cancer Biomarkers: The LOCCANDIA Integrated Platform
    Kalaitzakis, M.
    Kritsotakis, V.
    Grangeat, P.
    Paulus, C.
    Gerfault, L.
    Perez, M.
    Reina, C.
    Potamias, G.
    Tsiknakis, M.
    Kafetzopoulos, D.
    Binz, Pierre-Alain
    8TH IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOENGINEERING, VOLS 1 AND 2, 2008, : 129 - +
12345